Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 5;17(2):282-90.
doi: 10.1016/j.cmet.2013.01.007.

The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption

Affiliations

The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption

Sheila A Anderson et al. Cell Metab. .

Abstract

Red blood cell production is a finely tuned process that requires coordinated oxygen- and iron-dependent regulation of cell differentiation and iron metabolism. Here, we show that translational regulation of hypoxia-inducible factor 2α (HIF-2α) synthesis by iron regulatory protein 1 (IRP1) is critical for controlling erythrocyte number. IRP1-null (Irp1(-/-)) mice display a marked transient polycythemia. HIF-2α messenger RNA (mRNA) is derepressed in kidneys of Irp1(-/-) mice but not in kidneys of Irp2(-/-) mice, leading to increased renal erythropoietin (Epo) mRNA and inappropriately elevated serum Epo levels. Expression of the iron transport genes DCytb, Dmt1, and ferroportin, as well as other HIF-2α targets, is enhanced in Irp1(-/-) duodenum. Analysis of mRNA translation state in the liver revealed IRP1-dependent dysregulation of HIF-2α mRNA translation, whereas IRP2 deficiency derepressed translation of all other known 5' iron response element (IRE)-containing mRNAs expressed in the liver. These results uncover separable physiological roles of each IRP and identify IRP1 as a therapeutic target for manipulating HIF-2α action in hematologic, oncologic, and other disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Polycythemia and Extramedullary Erythropoiesis in IRP1-deficient Mice
[A] Rear paws showing greater redness in Irp1−/− mice. [B] Hematocrit for Irp1+/+ and Irp1−/− mice. Samples were collected from the retroorbital sinus or by cardiac puncture and hematocrit was from CBC analysis. See Table S1. For 30 wk Irp1+/+ mice n = 2. [C] Spleen from 6 wk old WT and Irp1−/− mice. [D] Spleen weight as a percent body weight as a function of age. For 30 wk Irp1+/+ mice n = 2. [E] H & E staining (top) or immunohistochemistry for TfR1 (CD71) (bottom) in spleen. [F] FACS analysis of cells isolated from bone marrow (BM) and spleen (SP) with staining for the erythroid marker Ter119 and CD71 (TfR). The cell populations are separated into stages I – IV reflecting increasing differentiation of the erythroblasts as described (Socolovsky et al., 2001). [G] Percentage of nucleated cells that are erythroblasts in BM and SP. [H] Erythroblast differentiation state in BM and SP as determined by FACS. For panels B, D, G and H results are expressed as mean ± SEM. * = P <0.05; ** = P < 0.01; *** = P < 0.001. Unless noted 5 wk old mice were used. See Tables S1, S3 and Figure S1.
Figure 2
Figure 2. Specific Increase in Erythroid Progenitors in Irp1−/− Mice
[A] Abundance of myeloid progenitor cells (LSK: lineage Sca-1+, c-kit+; MP: myeloid progenitors; CMP: common myeloid progenitors; GMP: granulocyte macrophage progenitors; MEP; megakaryocyte erythroid progenitors in spleen (SP) and bone marrow (BM). For panels B, C and D, BM and SP cells were isolated from Irp1+/+ and Irp1−/− mice and plated in duplicate in M3234 medium with 3 U/ml (B and C) or varying concentrations (D) of Epo. [B] Average percentage of maximum number of colonies formed in culture. For BFU-E (burst forming unit-erythroid), CFU-G (colony forming unit (CFU)-granulocyte), CFU-M (CFU-macrophage), CFU-GM (CFU-granulocyte-macrophage) and CFU-GEMM (CFU-granulocyte, erythroid, macrophage, megakaryocytic) colony formation, BM and SP cells were plated in M3434 medium, and colonies counted at day 7 after plating. [C] CFU-E (CFU-erythroid) number in BM and SP. [D] CFU-E number as a function of Epo concentration. Error bars show SEM. * p<0.05, ** p<0.01, *** p<0.001. Mice were 5 wk old.
Figure 3
Figure 3. HIF-2α Hyperactivity in IRP1-deficient Mice
[A] Serum Epo (pg/ml) in 4 wk, 5 wk and 8 wk old mice. [B] Kidney Epo mRNA level at 5 wk. [C] Erythroid differentiation gene mRNA levels in spleen at 5 wk. [D] Duodenal mRNA level for iron transport proteins and other HIF-2α (e.g. EGLN3) targets dependent on HIF-2α for induction in iron deficiency (5 wk). [E] Microarray analysis of duodenal mucosal cells at 5 wk. Response of each of 4 mice/genotype is shown. Posterior probability of differential expression for all genes is greater the 0.95. Expression of 5 erythroid genes (globin chains α1212 and ALAS2) is not shown. Results in this figure are expressed as mean ± SEM. * = P <0.05; ** = P < 0.01; *** = P < 0.001. (see Methods and Figure S2).
Figure 4
Figure 4. Selective Dysregulation of HIF-2α mRNA Translation in Irp1−/− Mice
[A] Kidney polysome profile (PP) analysis at 8 wk. A typical PP is shown. [B] Liver PP analysis at 8 wk. [C] EMSA from Irp2−/− or Irp1−/− kidney cytosol. Panels 1 and 2 show binding of RNAs (0.5 nM) using Irp2−/− kidney cytosol so binding is to IRP1. Panels 3 and 4 show binding of RNAs (0.5 nM) using Irp1−/− kidney cytosol so binding is to IRP2. Result is representative of n = 2 experiments. Proposed secondary structure of L-ferritin and HIF-2α IRE. [D] Model of the impact of IRP1 on HIF-2α regulation. Results in panels A and B are expressed as mean ± SEM * = P <0.05; ** = P < 0.01; *** = P < 0.001. See Tables S4 and S5.

References

    1. Anderson CP, Shen M, Eisenstein RS, Leibold EA. Mammalian iron metabolism and its control by IRPs. Biochim. Biophys. Acta. 2012;1823:1468–1483. - PMC - PubMed
    1. Andrews NC, Bridges KR. Disorders of iron metabolism and sideroblastic anemia. In: Nathan DG, Oski SH, editors. Nathan and Oski’s Hematology in Infancy and Childhood. W.B. Saunders; Philadelphia, PA: 1998. pp. 423–461.
    1. Bullock GC, Delehanty LL, Talbot AL, Gonias SL, Tong WH, Rouault TA, Dewar B, Macdonald JM, Chruma JJ, Goldfarb AN. Iron control of erythroid development by a novel aconitase-associated regulatory pathway. Blood. 2010;116:97–108. - PMC - PubMed
    1. Cooperman SS, Meyron-Holtz EG, Olivierre-Wilson H, Ghosh MC, McConnell JP, Rouault TA. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of IRP 2. Blood. 2005;106:1084–1091. - PMC - PubMed
    1. Davis MR, Shawron KM, Rendina E, Peterson SK, Lucas EA, Smith BJ, Clarke SL. Hif-2α is translationally repressed in response to dietary iron deficiency. J. Nutr. 2011;141:1590–1596. - PMC - PubMed

Publication types

MeSH terms